Clinical features of gastroesophageal reflux disease and erosive esophagitis: Insights from patients undergoing esophagogastroduodenoscopy in resource-limited Ethiopia

Table 2 Co-morbidities of patients with erosive esophagitis at Tikur Anbesa specialized hospital and Adera medical and surgical center during the study period

Co-morbidities	Number (n)	Percentage (%)
Diabetes mellitus	15/221	6.8
HTN	28/221	12.7
NAFLD	7/221	3.2
Dyslipidemia	13/221	5.9
CLD/PHTN	14/221	6.3
Asthma	4/221	1.8
IBS	20/221	9
Cholelithiasis	7/221	3.2
Scleroderma	3/221	1.4
Laryngopharyngeal Reflux	15/221	6.8

HTN: Hypertension; NAFLD: Nonalcoholic fatty liver disease; CLD: Chronic liver disease; PHTN: Portal hypertension; IBS: Irritable bowel syndrome.